Table 9.
Summary results for placebo-controlled studies for the treatment effects on the risk of disability progression and the relapse rate ratio in RRMS, using models with t-distributions and BRMA PNF for comparison.
| Relapse incidence rate ratio |
Disability relative risk |
|||||
|---|---|---|---|---|---|---|
| Model | Mean (SD) | 95% CrI | ψ 1 | Mean (SD) | 95% CrI | ψ 2 |
| BRMA PNF | 0.57 (0.06) | [0.46; 0.70] | 0.37 (0.09) | 0.75 (0.05) | [0.67; 0.86] | 0.07 (0.06) |
| BRMA PTDF (4 df) | 0.58 (0.07) | [0.46; 0.72] | 0.47 (0.14) | 0.75 (0.05) | [0.66; 0.85] | 0.08 (0.07) |
| BRMA PTDF (15 df) | 0.57 (0.06) | [0.45; 0.71] | 0.39 (0.10) | 0.75 (0.05) | [0.66; 0.85] | 0.08 (0.06) |
| BRMA PTDF (30 df) | 0.57 (0.06) | [0.45; 0.71] | 0.38 (0.10) | 0.75 (0.05) | [0.67; 0.85] | 0.07 (0.06) |